Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Heidrun Engler"'
Autor:
Beth Hutchins, Vellekamp Gary J, Suganto Sutjipto, Todd Machemer, Heidrun Engler, Drake LaFace, Elena Brin, Susan Cannon-Carlson, Douglas Cornell, Mark Horn, Marcio Voloch, Thomas Schluep, Van Tsai, Nico van Rooijen, Dan Maneval, Shu Fen Wen, Seoju Lee, Sundari Ravindran
Publikováno v:
Molecular Therapy. 12:254-263
Intravascular administration of recombinant adenovirus (rAd) in cancer patients has been well tolerated. However, dose-limiting hemodynamic responses associated with suppression of cardiac output have been observed at doses of 7.5 x 10(13) particles.
Autor:
Van Tsai, Heidrun Engler, Murali Ramachandra, Todd Machemer, Erlinda Quijano, Robert O. Ralston, Jennifer Philopena, Shu-Fen Wen
Publikováno v:
Virology. 328(1):52-61
Replication competent adenoviruses with various E1 modifications designed to restrict their replication to tumor cells are being evaluated as oncolytic agents in clinical trials. In mouse models, we observed that such oncolytic adenoviruses showed gr
Autor:
Heidrun Engler, William F. Benedict, Jain Hua Zhou, Bogdan Czerniak, Colin P.N. Dinney, Daniel C. Maneval, Takashi Karashima, Charles J. Rosser, Robert J. Connor, Xin Qiao Zhang, Motoyuki Yamashita
Publikováno v:
Cancer Gene Therapy. 9:687-691
Using our model to grow superficial human bladder cancer in the mouse bladder, we have found that the polyamide compound, Syn3, when injected intravesically for 1 hour at 1 mg/mL on two consecutive days, markedly increases rAd-beta-gal intravesical g
Autor:
Heidrun Engler, Mei Vaillancourt, John A. Howe, Duane E. Johnson, Paul W. Shabram, Aihua Zou, Murali Ramachandra, Amena Rahman, Barry J. Sugarman, Douglas Antelman, G. William Demers
Publikováno v:
Nature Biotechnology. 19:1035-1041
Replicating adenoviruses may prove to be effective anticancer agents if they can be engineered to selectively destroy tumor cells. We have constructed a virus (01/PEME) containing a novel regulatory circuit in which p53-dependent expression of an ant
Autor:
Barry J. Sugarman, John A. Howe, Machemer T, Nodelman M, Daniel C. Maneval, Demers Gw, Shu Fen Wen, Nagabhushan Tl, Wills Ken N, Duane E. Johnson, Heidrun Engler, Shinoda J, Beltran J, Iqbal Ahmed Cm
Publikováno v:
Cancer Gene Therapy. 8:788-795
A recombinant adenovirus expressing human interferon alpha2b driven by the cytomegalovirus promoter, IACB, was shown to produce and secrete biologically active protein in vitro and in vivo. Intravenous administration of IACB in Buffalo rats resulted
Publikováno v:
Urology. 66(1)
Objectives To evaluate whether a recombinant replication-deficient adenovirus containing the secreted human interferon alpha-2b gene (rAd-IFN) could improve the tissue and urine levels of IFN protein by transducing the urothelium with the secreted hu
Autor:
Suzie H. Pun, Nathalie C. Bellocq, Thomas Schluep, Greg Jensen, Todd Machemer, Erlinda Quijano, Jeremy D. Heidel, Shu-Fen Wen, Heidrun Engler, Mark E. Davis, Aijie Liu
Publikováno v:
Bioconjugate chemistry. 15(4)
Linear and branched poly(ethylenimines), lPEI and bPEI, respectively, grafted with beta-cyclodextrin are prepared to give CD-lPEI and CD-bPEI, respectively, and are investigated as in vitro and in vivo nonviral gene delivery agents. The in vitro toxi
Autor:
G William, Demers, Duane E, Johnson, Van, Tsai, Shu-Fen, Wen, Erlinda, Quijano, Todd, Machemer, Jennifer, Philopena, Murali, Ramachandra, John A, Howe, Paul, Shabram, Robert, Ralston, Heidrun, Engler
Publikováno v:
Cancer research. 63(14)
Central to the development of oncolytic virotherapies for cancer will be a better understanding of the parameters that influence the outcome of virotherapy to treat disseminated cancer by i.v. administration versus regional disease by local treatment
Autor:
Thomas Schluep, Maneval Daniel, Alexis E Harper, Shu-Fen Wen, Todd Machemer, Susan E. Conroy, Erlinda Quijano, Heidrun Engler, Ken N. Wills
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 7(4)
We conducted a series of experiments to determine if intraperitoneal (IP) delivery of recombinant adenovirus (rAd)-based therapies is improved through carrier vehicle selection, and compared an icodextrin solution (a high molecular weight dextrin wit
Autor:
Daniel C. Maneval, Christoph Huber, Jürgen Kuball, Derek Atkins, Grace Michael, Erlinda Quijano, Joachim W. Thüroff, Heidrun Engler, Mary Ann Fritz, Shu Fen Wen, Joachim Leissner, Beth Hutchins, S. Störkel, Patricia Meinhardt, Martin Schuler
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(4)
PURPOSE: To study safety, feasibility, and biologic activity of adenovirus-mediated p53 gene transfer in patients with bladder cancer. PATIENTS AND METHODS: Twelve patients with histologically confirmed bladder cancer scheduled for cystectomy were tr